Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Identify which bond taxes are lower in retirement and adjust your portfolio to reduce tax exposure while maintaining income.
23,881 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Foreclosure activity in April 2026 declined from March yet posted a double-digit year-over-year gain, underscoring on...
Trump’s move to bring Elon Musk into a China diplomacy frame marks a dramatic shift for investors. The pairing could ...
A hypothetical SpaceX IPO could ignite a wave for artificial intelligence (ai) stocks. This article identifies two le...
Singapore Airlines defends its decision to invest in Air India as it reports record revenue but a steep profit drop d...
Bitwise is set to list BHYP, a new ETF tracking Hyperliquid's HYPE token, on the NYSE. The move aims to give traditio...
A new platform built by a 20-year-old founder is aiming to reshape how Gen Z finds entry-level work. With a growing d...
As CME Group and ICE push 24/7 crypto trading, a heated clash with an offshore venue shines a spotlight on who contro...
Bitcoin sits in a delicate consolidation phase as traders grapple with potentially game-changing levels. On-chain dat...
KeyBanc boosts Okta's target to $103 from $95, citing a brighter security spending outlook and the central role of id...
ONE Sotheby’s International Realty expands into New Jersey by acquiring Callaway Henderson Sotheby’s International Re...
Opendoor expands its cash-offer toolkit through a RealScout integration, framing it as opendoor’s ‘grand reopening’: ...